Genomic Solutions to Launch Protein Tracker Software for Drug Discovery Process | GenomeWeb

If scientists thought genomics created a data bottleneck, what about proteomics?

Researchers trying to make sense of proteins often run thousands of gel samples per experiment. Each gel may have up to 800 spots worthy of further investigation, creating as many as 800,000 data points for a single experiment. If one of these spots proves to be novel and is a target for a drug, the ability to go back through each step in the drug discovery process is essential.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.